COMPARISON OF RISK FACTORS FOR POST-ERCP PANCREATITIS WITH ROUTINE INDOMETHACIN ADMINISTRATION

被引：0
|
作者：
Thiruvengadam, Nikhil R.
Forde, Kimberly A.
Chandrasekhara, Vinay
Ginsberg, Gregory G.
Kochman, Michael L.
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1226
引用
收藏
页码：S710 / S710
页数：1
相关论文
共 50 条
  • [1] Risk factors for post-ERCP pancreatitis
    Kadayifci, A.
    ENDOSCOPY, 2008, 40 (01) : 81 - 81
  • [2] Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Gwang Ha
    Eum, Jae Sup
    Lee, Sun Mi
    Song, Geun Am
    Kim, Dong Uk
    Kim, Il Doo
    Cho, Mong
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (04) : E11 - E18
  • [3] Indomethacin as prophylaxis for post-ERCP pancreatitis
    Arlt A.
    Der Gastroenterologe, 2016, 11 (4): : 317 - 318
  • [4] Outcomes and Risk Factors for Post-ERCP Pancreatitis
    Kim, Y. J.
    Kim, Y. T.
    Park, J. K.
    Park, S. C.
    Lee, S. H.
    PANCREAS, 2009, 38 (08) : 1015 - 1016
  • [5] Outcome and Risk Factors for Post-ERCP Pancreatitis
    Kim, Youn Joo
    Lee, Sang Hyub
    Yang, Ki Young
    Seo, Jeong Kyun
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB233 - AB234
  • [6] Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
    Akhter, Ahmed
    Pfau, Patrick R.
    Gopal, Deepak V.
    GASTROENTEROLOGY, 2016, 151 (03) : 568 - 569
  • [7] Nafamostat Mesilate in the Prevention of Post-ERCP Pancreatitis and Risk Factors for Post-ERCP Pancreattis
    Choi, Cheol Woong
    Kang, Dae Hwan
    Kim, Hyung Wook
    Park, Chan Ho
    Bae, Yong Mock
    Lee, Sang-Yong
    Park, Hyoung-Yoel
    Kim, Yong Wuk
    Lee, Jae Seung
    Kim, Jeong Yeol
    Heo, Jeung Ho
    Jeong, Eul Jo
    GASTROINTESTINAL ENDOSCOPY, 2009, 69 (05) : AB269 - AB269
  • [8] Rectal Indomethacin to Prevent Post-ERCP Pancreatitis
    Baron, Todd H.
    Abu Dayye, Barham K.
    Zinsmeister, Alan R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (03) : 277 - 278
  • [9] Risk factors for post-ERCP pancreatitis : it depends on the ERCP indication
    Koseoglu, H.
    Solakoglu, T.
    Basaran, M.
    Sari, S. Ozer
    Tahtaci, M.
    Yaman, S.
    Selvi, E.
    Ersoy, O.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2020, 83 (04) : 598 - 602
  • [10] Is indomethacin a new hope for post-ERCP pancreatitis?
    Bai, Yu
    Zou, Duowu
    Li, Zhaoshen
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 (09) : 2103 - 2103
12345